Copexis SA

The core activity of Copexis S.A. is consulting and supporting pharmaceutical development, particularly in the following areas: * Early-stage pharmaceutical development (from development candidate to clinical phase II) * Late-stage pharmaceutical development (clinical phase III and marketing authorization in Europe and Switzerland) * Strategic consulting and support for the implementation of solutions in the areas of: + Pharmaceutical manufacturing + Toxicology + Clinical trials + Regulatory affairs * Regulatory services (CH/EU) * Corporate development and management Copexis positions itself as a strategic partner for companies in the pharmaceutical industry, offering comprehensive consulting and support for pharmaceutical development.